CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 77 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $121,753 | +91.7% | 3,169 | +15.5% | 0.01% | +100.0% |
Q1 2023 | $63,524 | -19.3% | 2,744 | -8.7% | 0.00% | -25.0% |
Q4 2022 | $78,705 | +33.3% | 3,004 | 0.0% | 0.00% | +33.3% |
Q3 2022 | $59,059 | +27.3% | 3,004 | +13.2% | 0.00% | +50.0% |
Q2 2022 | $46,401 | +25.4% | 2,653 | +17.3% | 0.00% | +100.0% |
Q1 2022 | $36,990 | -76.3% | 2,261 | -76.4% | 0.00% | -50.0% |
Q4 2021 | $156,299 | +27.8% | 9,583 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $122,279 | -9.6% | 9,583 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $135,312 | +89.5% | 9,583 | +112.8% | 0.00% | +100.0% |
Q4 2020 | $71,418 | – | 4,503 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parallel Advisors, LLC | 5 | $0 | 0.00% |